PROTEOLOGICS - Tel Aviv Stock Exchang
PROTEOLOGICS - Tel Aviv Stock Exchang operates in Real Estate Development.
PROTEOLOGICS - Tel Aviv Stock Exchang (PRTL) - Net Assets
Latest net assets as of June 2018: ILA14.16 Million ILA
Based on the latest financial reports, PROTEOLOGICS - Tel Aviv Stock Exchang (PRTL) has net assets worth ILA14.16 Million ILA as of June 2018.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (ILA19.50 Million) and total liabilities (ILA5.34 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | ILA14.16 Million |
| % of Total Assets | 72.63% |
| Annual Growth Rate | N/A |
| 5-Year Change | -35.75% |
| 10-Year Change | N/A |
| Growth Volatility | 7.19 |
PROTEOLOGICS - Tel Aviv Stock Exchang - Net Assets Trend (2009–2017)
This chart illustrates how PROTEOLOGICS - Tel Aviv Stock Exchang's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for PROTEOLOGICS - Tel Aviv Stock Exchang (2009–2017)
The table below shows the annual net assets of PROTEOLOGICS - Tel Aviv Stock Exchang from 2009 to 2017.
| Year | Net Assets | Change |
|---|---|---|
| 2017-12-31 | ILA14.79 Million | -17.22% |
| 2016-12-31 | ILA17.87 Million | -0.96% |
| 2015-12-31 | ILA18.04 Million | -12.10% |
| 2014-12-31 | ILA20.52 Million | -10.85% |
| 2013-12-31 | ILA23.02 Million | -25.63% |
| 2012-12-31 | ILA30.95 Million | -19.78% |
| 2011-12-31 | ILA38.59 Million | -14.92% |
| 2010-12-31 | ILA45.35 Million | +244.14% |
| 2009-12-31 | ILA-31.46 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to PROTEOLOGICS - Tel Aviv Stock Exchang's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 0.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2017)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | ILA15.07 Million | 101.91% |
| Total Equity | ILA14.79 Million | 100.00% |
PROTEOLOGICS - Tel Aviv Stock Exchang Competitors by Market Cap
The table below lists competitors of PROTEOLOGICS - Tel Aviv Stock Exchang ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Black Rose Projects S.A.
WAR:BRP
|
$2.12K |
|
ATMP3F
SA:ATMP3F
|
$2.12K |
|
Indus Gas Limited
LSE:INDI
|
$2.12K |
|
Ekiosk
WAR:EKS
|
$2.12K |
|
Sidney Resources Corp
PINK:SDRC
|
$2.12K |
|
Traction Uranium Corp.
OTCQB:TRCTD
|
$2.11K |
|
Linklogis Inc. Class B
F:0NY
|
$2.11K |
|
American Noble Gas Inc.
OTCQB:AMNI
|
$2.11K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in PROTEOLOGICS - Tel Aviv Stock Exchang's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2016 to 2017, total equity changed from 17,868,000 to 14,792,000, a change of -3,076,000 (-17.2%).
- Other factors decreased equity by 3,076,000.
Equity Change Factors (2016 to 2017)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | ILA0.00 | -0.0% |
| Other Changes | ILA-3.08 Million | -20.8% |
| Total Change | ILA- | -17.22% |
Book Value vs Market Value Analysis
This analysis compares PROTEOLOGICS - Tel Aviv Stock Exchang's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Insufficient data available to analyze book value vs market value.
Capital Efficiency Dashboard
This dashboard shows how efficiently PROTEOLOGICS - Tel Aviv Stock Exchang utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Insufficient data available to analyze capital efficiency metrics.
Industry Comparison
This section compares PROTEOLOGICS - Tel Aviv Stock Exchang's net assets metrics with peer companies in the Other industry.
Industry Context
- Industry: Other
- Average net assets among peers: $35,706,800
- Average return on equity (ROE) among peers: -26.30%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| PROTEOLOGICS - Tel Aviv Stock Exchang (PRTL) | ILA14.16 Million | N/A | 0.38x | $2.12K |
| Biomedix Incubator Ltd (BMDX) | $22.00 Million | -65.28% | 0.03x | $119.97K |
| Black Sea Property PLC Ordinary Shares (BSP) | $1.91 Million | -202.26% | 1.13x | $54.45K |
| Ai Conversation Systems Ltd (FVT) | $22.19 Million | 66.99% | 2.97x | $7.32K |
| Gamatronic Electronic Industries Ltd (GAMT) | $108.08 Million | 0.13% | 0.24x | $38.22K |
| Panaxia Labs Israel Ltd (HROD) | $12.92 Million | -39.72% | 1.29x | $107.94K |
| The Israel Land Development Company Ltd (ILDA) | $21.85 Million | -30.46% | 0.50x | $30.38K |
| Insuline Medical Ltd (INSL) | $-2.26 Million | 0.00% | 0.00x | $6.99K |
| Itay Financial A.A Investments Ltd (ITYF) | $20.94 Million | 32.06% | 24.49x | $10.35K |
| Micronet Ltd (MCRNL) | $62.64 Million | -1.68% | 0.65x | $13.97K |
| Netz Hotels Ltd (NZHT) | $86.81 Million | -22.84% | 0.00x | $1.49K |